Protalix BioTherapeutics Inc.

05/21/2026 | Press release | Distributed by Public on 05/21/2026 05:03

Regulation FD Presentation (Form 8-K)

Protalix BioTherapeutics Inc. published this content on May 21, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 21, 2026 at 11:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]